WaferGen Bio-systems Reports Revenue Growth in Fourth Quarter of 2016 Preliminary fourth quarter 2016 revenue results represent 62% increase vs. 2015 PR Newswire FREMONT, Calif., Feb. 15, 2017...
WaferGen Bio-systems Regains Compliance with Nasdaq Listing Requirements PR Newswire FREMONT, Calif., Dec. 15, 2016 FREMONT, Calif., Dec. 15, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc...
WaferGen Bio-systems Announces 1-for-5 Reverse Stock Split PR Newswire FREMONT, Calif., Nov. 28, 2016 FREMONT, Calif., Nov. 28, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a...
WaferGen Bio-systems Announces Stockholder Approval of Merger with Takara Bio PR Newswire FREMONT, Calif., Nov. 15, 2016 FREMONT, Calif., Nov. 15, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc...
WaferGen Bio-systems Reports Results for Third Quarter 2016 Year-to-Date Revenues Represent 44% Growth over First Nine Months of 2015 PR Newswire FREMONT, Calif., Nov. 8, 2016 FREMONT, Calif...
WaferGen Bio-systems Reports Strong Revenue Growth in Third Quarter of 2016 Preliminary revenue results represent 42% increase through third quarter 2016 vs. 2015 Third Quarter 2016 Financial...
WaferGen Bio-systems Announces Adjournment of Special Meeting of Stockholders Stockholders are urged to vote "FOR" the proposed merger at or prior to the rescheduled special meeting on...
ISS and Glass Lewis Proxy Advisory Services Recommend WaferGen Bio-systems Stockholders Vote "FOR" Proposed Merger with Takara Bio WaferGen Urges Stockholders to Vote "FOR"...
WaferGen Presents Single-Cell T-Cell Receptor Sequencing Results Using the ICELL8™ Single-Cell System at the 2016 Single Cell Genomics Meeting Results Demonstrate Performance and Flexibility of...
WaferGen Bio-systems Reports Results for Second Quarter 2016 Second Quarter Revenues Represent 56% Growth over Second Quarter of 2015 and 30% Growth over First Quarter of 2016 PR...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales